ArthroCare Corp. announced that it has received clearance from the FDA to market its Parallax® Contour® Vertebral Augmentation Device (Contour) specifically for void creation in a vertebral body followed by injection of bone cement. Vertebral body void creation followed by bone cement augmentation is commonly used to treat painful vertebral compression fractures. The newly cleared Indication Statement provides that the Contour device is indicated for use during kyphoplasty or vertebral augmentation procedures.

Read the full story here

CareFusion announced the national commercial launch of the AVAmax® Vertebral Balloon, a minimally invasive device for use during kyphoplasty, a procedure for treating spinal compression fractures. The AVAmax Vertebral Balloon represents a competitive breakthrough and is expected to enhance the affordability of spinal fracture procedures. CareFusion’s vertebral balloon product and related components cost up to 40 percent less than similar kyphoplasty products on the market today, making the procedure more cost effective.

Read the full story here